IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 76 filers reported holding IMMUNOMEDICS INC in Q1 2014. The put-call ratio across all filers is 1.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $40,096,000 | +168.8% | 471,554 | +12.0% | 0.04% | +140.0% |
| Q2 2020 | $14,918,000 | +178.6% | 420,932 | +6.0% | 0.02% | +150.0% |
| Q1 2020 | $5,355,000 | -47.9% | 397,277 | -18.2% | 0.01% | -33.3% |
| Q4 2019 | $10,277,000 | +165.6% | 485,671 | +66.4% | 0.01% | +125.0% |
| Q3 2019 | $3,869,000 | +110.0% | 291,800 | +119.7% | 0.00% | +100.0% |
| Q2 2019 | $1,842,000 | -52.2% | 132,800 | -33.8% | 0.00% | -60.0% |
| Q1 2019 | $3,853,000 | +33.3% | 200,574 | -1.0% | 0.01% | +25.0% |
| Q4 2018 | $2,891,000 | -35.6% | 202,574 | -5.9% | 0.00% | -33.3% |
| Q3 2018 | $4,486,000 | +6.3% | 215,374 | +20.8% | 0.01% | 0.0% |
| Q2 2018 | $4,220,000 | +86.6% | 178,275 | +15.2% | 0.01% | +100.0% |
| Q1 2018 | $2,261,000 | -20.7% | 154,723 | -12.3% | 0.00% | -25.0% |
| Q4 2017 | $2,851,000 | +31.9% | 176,417 | +14.1% | 0.00% | +33.3% |
| Q3 2017 | $2,162,000 | +110.5% | 154,647 | +33.0% | 0.00% | +50.0% |
| Q2 2017 | $1,027,000 | +36.6% | 116,300 | 0.0% | 0.00% | +100.0% |
| Q1 2017 | $752,000 | +68.6% | 116,300 | -4.2% | 0.00% | 0.0% |
| Q4 2016 | $446,000 | +7.5% | 121,400 | -4.9% | 0.00% | 0.0% |
| Q3 2016 | $415,000 | +30.9% | 127,600 | -6.5% | 0.00% | 0.0% |
| Q2 2016 | $317,000 | -9.9% | 136,500 | -3.1% | 0.00% | 0.0% |
| Q1 2016 | $352,000 | -23.3% | 140,800 | -5.8% | 0.00% | 0.0% |
| Q4 2015 | $459,000 | +78.6% | 149,400 | 0.0% | 0.00% | – |
| Q3 2015 | $257,000 | -57.7% | 149,400 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $607,000 | -17.1% | 149,400 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $732,000 | 0.0% | 149,400 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $732,000 | +31.7% | 149,400 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $556,000 | +2.0% | 149,400 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $545,000 | -10.1% | 149,400 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $606,000 | -3.2% | 149,400 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $626,000 | -34.0% | 149,400 | -2.5% | 0.00% | -50.0% |
| Q3 2013 | $948,000 | +39.0% | 153,194 | +22.2% | 0.00% | +100.0% |
| Q2 2013 | $682,000 | – | 125,394 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 4,750,000 | $112,433,000 | 20.02% |
| Avoro Capital Advisors LLC | 17,714,461 | $419,301,000 | 16.14% |
| Foresite Capital Management III, LLC | 2,541,729 | $60,163,000 | 12.96% |
| Foresite Capital Management IV, LLC | 1,231,543 | $29,151,000 | 9.94% |
| Ghost Tree Capital, LLC | 1,250,000 | $29,588,000 | 8.71% |
| NEXTHERA CAPITAL LP | 1,329,104 | $31,460,000 | 4.87% |
| RA Capital Management | 3,119,778 | $73,845,000 | 4.79% |
| DLD Asset Management, LP | 2,682,100 | $63,458,000 | 4.78% |
| Palo Alto Investors LP | 4,803,364 | $113,696,000 | 4.54% |
| DLD Asset Management, LP | 2,411,600 | $57,058,000 | 4.30% |